Education

M.S. in Health Analysis, Universidad Complutense de Madrid, España, 2011

Current position

Ph.D. student in Oncology, IIS Puerta de Hierro-Majadahonda (07/2010-present)

Publications

1. Rodriguez, M., Silva, J., Herrera, A., Herrera, M., Pena, C., Martin, P., Gil-Calderon, B., Larriba, M. J., Coronado, M. J., Soldevilla, B., Turrion, V. S., Provencio, M., Sanchez, A., Bonilla, F. and Garcia-Barberan, V. (2015). Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer. Oncotarget 6(38): 40575-40587.
2. Herrera, M., Herrera, A., Larriba, M. J., Ferrer-Mayorga, G., Herreros, A. G., Bonilla, F., Baulida, J. and Peña, C. (2016). Colon cancer-associated fibroblast establishment and culture growth. Bio-protocol 6(7): e1773.
   
3. Herrera, A., Herrera, M., Alba-Castellon, L., Silva, J., Garcia, V., Loubat-Casanovas, J., Alvarez-Cienfuegos, A., Miguel Garcia, J., Rodriguez, R., Gil, B., Ma Jesus, C., Ma Jesus, L., Ignacio Casal, J., de Herreros, A. G., Bonilla, F. and Pena, C. (2014). Protumorigenic effects of Snail-expression fibroblasts on colon cancer cells. Int J Cancer 134(12): 2984-2990.
   
4. Herrera, A., Herrera, M., Bonilla, F., de Herreros, A. G. and Peña, C. (2014). Snail1-expressing fibroblasts as a source of paracrine signals in colon cancer tumors. Cancer Cell & Microenvironment 1(4).
   
5. Herrera, M.*, Herrera, A.*, Dominguez, G., Silva, J., Garcia, V., Garcia, J. M., Gomez, I., Soldevilla, B., Munoz, C., Provencio, M., Campos-Martin, Y., Garcia de Herreros, A., Casal, I., Bonilla, F. and Pena, C. (2013). Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients. Cancer Sci 104(4): 437-444. (*Both authors contributed equally to this work)
   
6. Herrera, M., Islam, A. B., Herrera, A., Martin, P., Garcia, V., Silva, J., Garcia, J. M., Salas, C., Casal, I., de Herreros, A. G., Bonilla, F. and Pena, C. (2013). Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature. Clin Cancer Res 19(21): 5914-5926.
   
7. Mohammed, N., Rodriguez, M., Garcia, V., Garcia, J. M., Dominguez, G., Pena, C., Herrera, M., Gomez, I., Diaz, R., Soldevilla, B., Herrera, A., Silva, J. and Bonilla, F. (2011). EPAS1 mRNA in plasma from colorectal cancer patients is associated with poor outcome in advanced stages. Oncol Lett 2(4): 7.